Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats

BACKGROUND AND AIM: Dasatinib is approved for the treatment of leukaemia worldwide. Triazole agents such as posaconazole may be used for the control of secondary fungal infection with leukaemia. This work aimed to develop a bioanalytical method to study the potential interaction between dasatinib an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Suili, Zhang, Xiaoshan, Wang, Yuzhen, Wen, Congcong, Wang, Chenxiang, Zhou, Ziye, Lin, Guanyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163634/
https://www.ncbi.nlm.nih.gov/pubmed/34079220
http://dx.doi.org/10.2147/DDDT.S301241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163634/
https://www.ncbi.nlm.nih.gov/pubmed/34079220
http://dx.doi.org/10.2147/DDDT.S301241

Ejemplares similares